Inhibition of aldo-keto reductase 1C3 overcomes gemcitabine/cisplatin resistance in bladder cancer
Rin Himura, Shinya Kawano, Yujiro Nagata, Mina Kawai, Atsumi Ota, Yudai Kudo, Yuta Yoshino, Naohiro Fujimoto, Hiroshi Miyamoto, Satoshi Endo, Akira Ikari
Topics & Concepts
Bladder cancerAndrogen receptorGemcitabineCancer researchProstate cancerCisplatinAldo-keto reductaseCancerDihydrotestosteroneApoptosisAndrogenCancer cellInternal medicineBiologyMedicineEndocrinologyReductaseChemotherapyHormoneEnzymeBiochemistryBladder and Urothelial Cancer TreatmentsAldose Reductase and TaurineProstate Cancer Treatment and Research